Announcements
Sidley Represents Capricor Therapeutics in Common Stock Offering
October 24, 2024
Sidley represented Capricor Therapeutics, Inc. in connection with an underwritten public offering of 5,073,800 shares of its common stock, including the exercise in full of the underwriters’ option to purchase additional shares to cover overallotments, bringing the total gross proceeds to Capricor from the offering to approximately US$86.3 million. Piper Sandler & Co. and Oppenheimer & Co. Inc. acted as the joint book-running managers for the offering.
The deal team was led by Rob Carlson and included Nick DeAngelis and Nithya Swaminathan.
連絡先
得意分野
Suggested News & Insights
U.S. SEC Grants Exemption From Section 16(a) Reporting Obligations to Directors and Officers of Certain Foreign Private IssuersMay 22, 2026Sidley Advises Bank RBK on Its Debut US$300 Million Eurobond OfferingMay 21, 2026Sidley Advises on Genting Group’s Landmark US$1.25 Billion Perpetual Securities Issuance and Concurrent US$1.5 Billion Tender OfferMay 20, 2026Sidley Advises UISEE Technologies on Its Successful Chapter 18C Listing in Hong KongMay 20, 2026Sidley Advises the Joint Global Coordinators, Dealer Managers and Joint Bookrunners on QazaqGaz’s US$700 Million Bond Offering and Liability Management ExerciseMay 18, 2026Sidley Wins “Innovative Lawyers in Disputes” Award at the FT Innovative Lawyers Awards Asia-Pacific 2026May 14, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory